Methods of administering amantadine
US10154971B2 · kind B2 · utility
8Cited by
118References
56Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2014 |
| Grant date | Dec 18, 2018 |
| Priority date | — |
| Expiry date | Dec 4, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/5047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.